1163 related articles for article (PubMed ID: 29991128)
21. Integrated analysis identifies a long non-coding RNAs-messenger RNAs signature for prediction of prognosis in hepatitis B virus-hepatocellular carcinoma patients.
Bai Z; Li H; Li C; Sheng C; Zhao X
Medicine (Baltimore); 2020 Oct; 99(40):e21503. PubMed ID: 33019382
[TBL] [Abstract][Full Text] [Related]
22. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
Fan CN; Ma L; Liu N
J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
[TBL] [Abstract][Full Text] [Related]
23. Genome-Wide Analysis of Prognostic lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Hepatocellular Carcinoma.
Lin P; Wen DY; Li Q; He Y; Yang H; Chen G
Cell Physiol Biochem; 2018; 48(5):1953-1967. PubMed ID: 30092571
[TBL] [Abstract][Full Text] [Related]
24. Screening key lncRNAs for human lung adenocarcinoma based on machine learning and weighted gene co-expression network analysis.
Wang Y; Fu J; Wang Z; Lv Z; Fan Z; Lei T
Cancer Biomark; 2019; 25(4):313-324. PubMed ID: 31322548
[TBL] [Abstract][Full Text] [Related]
25. Combined identification of three lncRNAs in serum as effective diagnostic and prognostic biomarkers for hepatitis B virus-related hepatocellular carcinoma.
Fu P; Gong B; Li H; Luo Q; Huang Z; Shan R; Li J; Yan S
Int J Cancer; 2022 Nov; 151(10):1824-1834. PubMed ID: 35802466
[TBL] [Abstract][Full Text] [Related]
26. Investigation of serum lncRNA-uc003wbd and lncRNA-AF085935 expression profile in patients with hepatocellular carcinoma and HBV.
Lu J; Xie F; Geng L; Shen W; Sui C; Yang J
Tumour Biol; 2015 May; 36(5):3231-6. PubMed ID: 25501706
[TBL] [Abstract][Full Text] [Related]
27. Construction of a long non-coding RNA-associated ceRNA network reveals potential prognostic lncRNA biomarkers in hepatocellular carcinoma.
Yan Y; Yu J; Liu H; Guo S; Zhang Y; Ye Y; Xu L; Ming L
Pathol Res Pract; 2018 Dec; 214(12):2031-2038. PubMed ID: 30316688
[TBL] [Abstract][Full Text] [Related]
28. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
Zhao QJ; Zhang J; Xu L; Liu FF
World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
[TBL] [Abstract][Full Text] [Related]
29. Comprehensive analysis of key genes, microRNAs and long non-coding RNAs in hepatocellular carcinoma.
Shi B; Zhang X; Chao L; Zheng Y; Tan Y; Wang L; Zhang W
FEBS Open Bio; 2018 Sep; 8(9):1424-1436. PubMed ID: 30186744
[TBL] [Abstract][Full Text] [Related]
30. Novel Long Noncoding RNAs,
Qin Y; Tu X; Huang M; Ma C; Huang Q; Huang Q; Shu H; Ou C
DNA Cell Biol; 2023 Aug; 42(8):488-497. PubMed ID: 37527208
[TBL] [Abstract][Full Text] [Related]
31. Identification of key long non-coding RNAs in gastric adenocarcinoma.
Fu T; Ji X; Bu Z; Zhang J; Wu X; Zong X; Fan B; Jia Z; Ji J
Cancer Biomark; 2020; 27(4):541-553. PubMed ID: 32176636
[TBL] [Abstract][Full Text] [Related]
32. Construction of a disease-specific lncRNA-miRNA-mRNA regulatory network reveals potential regulatory axes and prognostic biomarkers for hepatocellular carcinoma.
Zhang Q; Sun L; Zhang Q; Zhang W; Tian W; Liu M; Wang Y
Cancer Med; 2020 Dec; 9(24):9219-9235. PubMed ID: 33232580
[TBL] [Abstract][Full Text] [Related]
33. Screening lncRNAs with diagnostic and prognostic value for human stomach adenocarcinoma based on machine learning and mRNA-lncRNA co-expression network analysis.
Li Q; Liu X; Gu J; Zhu J; Wei Z; Huang H
Mol Genet Genomic Med; 2020 Nov; 8(11):e1512. PubMed ID: 33002344
[TBL] [Abstract][Full Text] [Related]
34. Competing endogenous RNA network and prognostic nomograms for hepatocellular carcinoma patients who underwent R0 resection.
Li Y; Ma B; Yin Z; Liu P; Liu J; Li J; Wang F; Chen H
J Cell Physiol; 2019 Nov; 234(11):20342-20353. PubMed ID: 30963571
[TBL] [Abstract][Full Text] [Related]
35. A novel lncRNA, TCONS_00006195, represses hepatocellular carcinoma progression by inhibiting enzymatic activity of ENO1.
Yu S; Li N; Huang Z; Chen R; Yi P; Kang R; Tang D; Hu X; Fan X
Cell Death Dis; 2018 Dec; 9(12):1184. PubMed ID: 30518748
[TBL] [Abstract][Full Text] [Related]
36. Identification of differentially expressed lncRNAs and mRNAs in luminal-B breast cancer by RNA-sequencing.
Yuan CL; Jiang XM; Yi Y; E JF; Zhang ND; Luo X; Zou N; Wei W; Liu YY
BMC Cancer; 2019 Dec; 19(1):1171. PubMed ID: 31795964
[TBL] [Abstract][Full Text] [Related]
37. A novel seven-lncRNA signature for prognosis prediction in hepatocellular carcinoma.
Yan J; Zhou C; Guo K; Li Q; Wang Z
J Cell Biochem; 2019 Jan; 120(1):213-223. PubMed ID: 30206981
[TBL] [Abstract][Full Text] [Related]
38. Microarray analysis on the lncRNA expression profile in male hepatocelluar carcinoma patients with chronic hepatitis B virus infection.
Niu J; Lin Y; Liu P; Yu Y; Su C; Wang X
Oncotarget; 2016 Nov; 7(46):76169-76180. PubMed ID: 27769059
[TBL] [Abstract][Full Text] [Related]
39. RNA sequencing reveals the long noncoding RNA and mRNA profiles and identifies long non-coding RNA TSPAN12 as a potential microvascular invasion-related biomarker in hepatocellular carcinoma.
Lu J; Li B; Xiong X; Cheng N
Biomed Pharmacother; 2020 Jun; 126():110111. PubMed ID: 32222644
[TBL] [Abstract][Full Text] [Related]
40. Long non‑coding RNA‑based risk scoring system predicts prognosis of alcohol‑related hepatocellular carcinoma.
Luo Y; Ye J; Wei J; Zhang J; Li Y
Mol Med Rep; 2020 Aug; 22(2):997-1007. PubMed ID: 32468063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
